Sarepta Therapeutics, Inc.
SRPT
$16.66
$0.261.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -30.64% | -28.99% | -45.21% | -62.41% | -19.18% |
| Total Receivables | -20.27% | 4.96% | 55.41% | 72.76% | 49.14% |
| Inventory | 21.97% | 90.34% | 104.62% | 152.04% | 132.29% |
| Prepaid Expenses | -11.07% | -5.36% | 0.05% | -14.60% | 18.97% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -52.60% | -40.38% | -29.57% | -13.12% | 145.77% |
| Total Current Assets | -17.42% | 1.38% | -0.99% | -1.31% | 19.16% |
|
|
|||||
| Total Current Assets | -17.42% | 1.38% | -0.99% | -1.31% | 19.16% |
| Net Property, Plant & Equipment | -3.69% | 11.51% | 28.66% | 35.17% | 36.84% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 7.67% | 7.67% | 8.03% | -9.44% | -9.23% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 27.11% | -7.75% | 43.05% | 23.52% | -18.73% |
| Total Assets | -15.48% | -2.96% | 7.46% | 7.47% | 21.40% |
|
|
|||||
| Total Accounts Payable | 30.96% | -20.85% | 27.26% | 70.54% | 30.03% |
| Total Accrued Expenses | -3.88% | -27.20% | -0.56% | 14.44% | 24.78% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -90.66% | -90.41% | -89.35% | -- |
| Total Finance Division Other Current Liabilities | 109.37% | 158.41% | 113.35% | 7.80% | 45.83% |
| Total Other Current Liabilities | 109.37% | 158.41% | 113.35% | 7.80% | 45.83% |
| Total Current Liabilities | 49.69% | 31.73% | 33.62% | -0.51% | 11.94% |
|
|
|||||
| Total Current Liabilities | 49.69% | 31.73% | 33.62% | -0.51% | 11.94% |
| Long-Term Debt | -27.10% | -8.88% | 0.41% | 0.41% | 0.41% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.59% | 26.49% | 49.32% | 46.65% | 36.54% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -77.16% | -99.54% | -87.22% | -1.94% | -21.74% |
| Total Liabilities | -9.29% | -8.64% | -1.05% | 2.63% | 1.26% |
|
|
|||||
| Common Stock & APIC | 5.29% | 7.12% | 6.61% | 7.99% | 8.19% |
| Retained Earnings | -15.82% | -6.21% | -1.32% | -5.63% | 5.29% |
| Treasury Stock & Other | -11,363.76% | -1,215.50% | -2,357.67% | 104.92% | -123.75% |
| Total Common Equity | -25.34% | 8.11% | 26.03% | 18.89% | 77.78% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -25.34% | 8.11% | 26.03% | 18.89% | 77.78% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -25.34% | 8.11% | 26.03% | 18.89% | 77.78% |
|
|
|||||